TherapeuticsMD, Inc. — Director's Dealing 2015

May 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2015-05-12

Reporting Person: Russell Angus C. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-12	Common Stock	P	35000	$6.1519	Acquired	35000	Direct

Footnotes

F1: This transaction was executed in multiple trades ranging from $6.0350 to $6.1600; the price reported reflects the weighted average price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request of the SEC staff, the issuer or a security holder of the issuer.